openPR Logo
Press release

Alzheimer Diagnostic Tests Market 2018-2025: Key Companies Profile, Market Size Estimation, Consumption, Supply and Demand Analysis

12-13-2018 01:38 PM CET | Health & Medicine

Press release from: Adroit Market Research

Adroit Market Research

Adroit Market Research

The global Alzheimer's diagnostic test market in research settings has evolved rapidly over the past few decades. The US National Institute, International Working Group (IWG) on Aging and Alzheimer's Association (NIA-AA) are together contributing towards the efforts of amalgamating biomarkers to research diagnostic criteria. Alzheimers is one of the primary cause of mortality in the United States. The Alzheimer's diagnostic test market is expected to reach xx USD billion by the end of forecast period (2018-2025) growing at a CAGR of xx%.

Request PDF Sample Copy of Alzheimer's Diagnostic Test Market Report at: https://www.adroitmarketresearch.com/contacts/request-sample/80

Disease that leads to dementia is Alzheimer's — an array of brain disorders that destroys social and intellectual skills of an individual. This disease tends to degenerate brain cells and then pass away, rendering decline in memory and its function. At initial stage of the Alzheimer's disease, individuals may face difficulty remembering and notice mild confusion. Eventually, they forget key things of day-to-day life and suffer drastic personality disorders.

Moreover, growing number of Alzheimer’s cases has led to the rapid development of Alzheimer's diagnostic test market size. However, one of the primary factor contributing towards the market is, growing number of elderly population. Since the disease at onset is not easily detected, developing innovative diagnostics procedure and tools has been highly emphasized. In addition, Alzheimer’s is most common neuro degenerative disorder, still plentiful amount of R & D is conducted to identify suitable treatment and diagnostic for Alzheimer's diagnostic test industry.

Read more details of Alzheimer's diagnostic test market report at: https://www.adroitmarketresearch.com/industry-reports/alzheimers-diagnostic-test-market

Causes of Alzheimer’s disease

Diagnose of a medical condition, professionals need to identify the cause behind the disease. Alzheimer’s cause is vague. But lifestyle, genetics and environment are major contributing factors for Alzheimer’s disease. However, the fact is, Alzheimer’s destroys brain cells leading to brain shrinking. Individuals with Alzheimer’s has two defined abnormality including plaques and tangles.

Plaques: These are clumps of protein called amyloid plaques, interfere communication between brain cells leading to damage and eventually death of brain cells.

Tangles: The system that passes nutrients to other body parts from brain is a protein named Tau. Threads of these proteins in individual suffering from Alzheimer’s, begin to collect in the brain cells thus prevent nutrients to pass on.

Genetics: The Apo lipoprotein E gene (APOE) has its parts in later stages of Alzheimer’s. However, it’s not necessary to have Alzheimer while having this gene. Most early-onset cases are caused by alteration in certain genes which are inherited.

Enquire more details of Alzheimer's diagnostic test market report at: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/80

Diagnosing Methods

Diagnosing Alzheimer's involves a complete assessment that considers all possible causes starting from medical history assessment to brain tests.

Medical history: While examining medical history of a patient, health care providers interrogate past as well as current illness, and medications patient is undergoing. Even the medical professionals enquires about medical conditions affecting patient’ Physical exam and diagnostic tests.

Physical exam and diagnostic tests: During a medical workup, physicians check blood pressure, pulse and temperature. Take notes on heartbeats and lungs. Even collect blood or urine samples for laboratory testing.

Information collected from a laboratory tests and physical exam helps in recognizing health issues that are causing symptoms of dementia. Medical conditions apart from Alzheimer’s that may led to memory problems, trouble focusing and confused thinking include kidney disease, liver disease, thyroid abnormalities, anemia, infection, diabetes, etc.

Neurological exam: During a neurological exam, the physician tests closely Reflexes, Eye movement, Coordination, Speech and Sensation to evaluate the patient for problems that may indicate brain disorders other than Alzheimer's. Healthcare provider look for signs of Parkinson's disease, small or large strokes, fluid accumulation on the brain, brain tumors and other illnesses.

Mental status tests: This test evaluates memory, thinking skills and ability to solve simple problems. Such tests examine overall sense of whether a person knows the date, time, and space, aware of symptoms, ability to learn short list of words, do simple calculation and follow instructions.

Mini-Mental State Exam (MMSE) Test: A patient has to answer a questionnaire prepared by a health professional which has series of questions test everyday mental skills. A score from 20 to 24, 13 to 20 and less than 12 suggests mild dementia, moderate dementia, and severe dementia respectively.

Mini-Cog Test: A person has to complete two tasks: Remember and recall three common objects after several minutes and Drawing a clock with 12 numbers and time specified by examiner.

Regional Analysis of Global Alzheimer’s Disease Diagnostic Market:

North America accounts for largest Alzheimer's diagnostic test market share. Europe comes at the second place for Alzheimer’s disease diagnostic. Furthermore, Asia Pacific is anticipated to be the fastest growing region in Alzheimer’s disease diagnostic test market size.

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Ryan Johnson

Adroit Market Research

3131 McKinney Ave Ste 600,

Dallas, Texas – 75204, U.S.A

Phone No: +1 (214) 884-6068

Email: sales@adroitmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer Diagnostic Tests Market 2018-2025: Key Companies Profile, Market Size Estimation, Consumption, Supply and Demand Analysis here

News-ID: 1438614 • Views:

More Releases from Adroit Market Research

Electronic Health Records Market Estimated Size Valuation will be USD 47.62 Billion Growing at a CAGR of 6.01% from 2024 to 2032 | Adroit Market Research
Electronic Health Records Market Estimated Size Valuation will be USD 47.62 Bill …
The global Electronic Health Records market reached a value of US$ 30.65 Billion in 2023 and is expected to reach US$ 47.62 Billion by 2032, exhibiting a CAGR of 6.01% during the prediction period of 2023 to 2032. Executive Synopsis: The last few years have seen a notable increase in the global Electronic Health Records market because of technological breakthroughs, rising demand from a variety of industries, and continuous R&D initiatives to
Organic Food Market Size to Reach USD 525.65 Billion at a CAGR of 12.09% by 2032 - Growth Opportunities, Strategic Initiatives, Trends & Innovation | Adroit Market Research
Organic Food Market Size to Reach USD 525.65 Billion at a CAGR of 12.09% by 2032 …
The global Organic Food market reached a value of US$ 170.05 Billion in 2023 and is expected to reach US$ 525.65 Billion by 2032, exhibiting a CAGR of 12.09% during the prediction period of 2023 to 2032. The global Organic Food market report uses methods and major market analysis To give a thorough picture of the market, the global Organic Food market report uses a range of analytical techniques and frameworks. Market
Quantum Computing Market Size to Grow Worth USD 888.5 Million at a CAGR of 33.10% by 2032 - Top Players, Trends, Growth Prospects & Forecast | Adroit Market Research
Quantum Computing Market Size to Grow Worth USD 888.5 Million at a CAGR of 33.10 …
The global Quantum Computing market reached a value of US$ 888.5 Million in 2023 and is expected to reach US$ 12,622.9 Million by 2032, exhibiting a CAGR of 33.10% during the prediction period of 2023 to 2032. What is said in the market report for global Quantum Computing A thorough examination of the market's structure, trends, obstacles, and opportunities is included in the global Quantum Computing market study. A thorough analysis of
Software as a Service Market Size to grow USD 1,230.81 Billion by 2032 | CAGR of 19.5% - Trends, Technical Advancement & Future Prospect - Adroit Market Research
Software as a Service Market Size to grow USD 1,230.81 Billion by 2032 | CAGR of …
The global Software as a Service market reached a value of US$ 275.53 Billion in 2023 and is expected to reach US$ 1,230.81 Billion by 2032, exhibiting a CAGR of 19.5% during the prediction period of 2023 to 2032. Extensive Assessment of COVID-19's Impact on the Worldwide Software as a Service Industry The COVID-19 pandemic had a substantial effect on the global Software as a Service market, altering market dynamics through supply

All 5 Releases


More Releases for Alzheimer

Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion. Data Bridge
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as